Ensat HT is a brand that is part of the EU-funded Horizon 2020 research and innovation project. The goal of this project is to investigate hypertension and develop personalized approaches to treatment and disease management. The brand offers a range of products and services through its work packages.

Work Package 1 focuses on bioinformatic modeling and data management, providing the expertise and infrastructure needed to support the project. Work Package 2 provides genomics and genetic data from multiple platforms, which is combined with data from Work Package 3 to create a multidimensional bioinformatic model in Work Package 1. This model is then used to identify molecular signatures and omics-based circulating biomarkers in Work Package 4.

Work Package 3 is dedicated to identifying and validating metabolomics-derived biomarkers for different forms of endocrine hypertension. Work Package 4 conducts clinical studies to assess the validity and usefulness of the identified omics signatures for patient identification and risk stratification. Work Package 5 aims to assess and validate the approach for stratified health promotion, while Work Package 6 focuses on dissemination, exploitation, and IP management of the project results.

Finally, Work Package 7 handles the management tasks of the project. With its innovative research and multidimensional approach, Ensat HT is at the forefront of hypertension investigation, aiming to improve patient outcomes and revolutionize disease management